Michael Ah You
Psychiatric/Mental Health · Payson, UTNPI 1396412698
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 231 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,345 and has fallen 52.2% since, to $642 in 2025. Among psychiatric/mental health clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$759
- Otsuka America Pharmaceutical, Inc.$739
- AbbVie$578
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$485
- Neurocrine Biosciences, Inc.$473
- Alkermes, Inc.$329
- plus $1K from 11 others
What the payments were for
- Food & beverage$4,429100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 38 | $759 |
| Otsuka America Pharmaceutical, Inc. | 41 | $739 |
| AbbVie | 42 | $578 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $485 |
| Neurocrine Biosciences, Inc. | 19 | $473 |
| Alkermes, Inc. | 18 | $329 |
| Johnson & Johnson | 11 | $296 |
| Lundbeck LLC | 13 | $240 |
| Axsome Therapeutics, Inc. | 8 | $138 |
| Sunovion Pharmaceuticals Inc. | 7 | $114 |
| Tris Pharma Inc | 3 | $68 |
| Corium, LLC | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Almatica Pharma LLC | 2 | $40 |
| Idorsia Pharmaceuticals US Inc | 2 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$123
- Austedo XR$119
- AUSTEDO$116
- REXULTI$115
- SPRAVATO$106
How this compares
$4,429 in reported general payments places this provider in the 90th percentile of 393 psychiatric/mental health providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $93,658 |
| Quetiapine Fumarate | 12 | $440 |
| Trazodone Hcl | 21 | $205 |
| Propranolol Hcl | 16 | $188 |
| Eszopiclone | 11 | $107 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $473 | $93,65812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 393 psychiatric/mental health providers in Utah.
Other psychiatric/mental health in Payson
- Bret HafenLayton$381K
- Alberto SouzaSaint George$114K
- Anthony BrowningOrem$32K
- Debra HainRiverton$29K
- Kristin BarberSalt Lake City$28K
- Briana TerrySalt Lake City$14K
- Paige MarshallSaint George$13K
- Derick MoodySpringville$8K
- Sumer AndersonSandy$8K
- Colby JamesLayton$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.